Table 1.
Measurement of GSTP+ and CK19+ focal lesions
| GSTP+ nodules (No./cm2) | GSTP+ area (% of total liver area) | CK19+ nodules (% of GSTP+ nodules) | CK19+ area (% of total liver area) | ||
|---|---|---|---|---|---|
| BN 190 | P | 10,89 | 21,70% | 36,36% | 4,11% |
| R | 12,87 | 14,33% | 0,00% | 0,00% | |
| BN 191 | P | 6,57 | 17,18% | 50,00% | 4,51% |
| R | 31,57 | 36,15% | 10,42% | 1,51% | |
| BN 192 | P | 4,66 | 5,27% | 57,14% | 2,18% |
| R | 36,00 | 12,24% | 5,56% | 0,61% | |
| BN 193 | P | 11,53 | 15,54% | 53,33% | 5,11% |
| R | 24,61 | 25,23% | 21,88% | 1,06% | |
| BN 194 | P | 13,91 | 26,93% | 43,75% | 10,81% |
| R | 14,78 | 23,35% | 29,41% | 2,47% | |
| BN 195 | P | 7,33 | 11,35% | 37,50% | 1,52% |
| R | 19,26 | 18,47% | 19,05% | 2,00% | |
| MEAN | P | 9,148 | 16,33% | 46,35% | 4,71% |
| R | 23,181 | 21,63% | 14,38% | 1,27% | |
P: Persistent, R: Remodeling